Drug intelligence / Profile preview

coconut oil + epigallocatechin gallate

Development stage: Unknown
Administration: Oral

Overview

A combination of coconut oil and epigallocatechin gallate (EGCG), the main component of green tea. This combination has shown beneficial effects in multiple sclerosis (MS) patients, including improvements in metabolic health markers, functional abilities such as gait speed and balance, and reductions in depression and anxiety. The mechanism involves anti-inflammatory and antioxidant effects from EGCG, while coconut oil affects fat metabolism and energy production through medium-chain triglycerides.

Targets

IL-6 (Interleukin 6)

Beyond the preview

Go deeper on coconut oil + epigallocatechin gallate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on coconut oil + epigallocatechin gallate.

Explore the full profile